1. Home
  2. BMRN vs CLH Comparison

BMRN vs CLH Comparison

Compare BMRN & CLH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMRN
  • CLH
  • Stock Information
  • Founded
  • BMRN 1996
  • CLH 1980
  • Country
  • BMRN United States
  • CLH United States
  • Employees
  • BMRN N/A
  • CLH 25232
  • Industry
  • BMRN Biotechnology: Pharmaceutical Preparations
  • CLH Environmental Services
  • Sector
  • BMRN Health Care
  • CLH Industrials
  • Exchange
  • BMRN Nasdaq
  • CLH Nasdaq
  • Market Cap
  • BMRN 12.1B
  • CLH 12.2B
  • IPO Year
  • BMRN 1999
  • CLH 1987
  • Fundamental
  • Price
  • BMRN $55.00
  • CLH $226.16
  • Analyst Decision
  • BMRN Buy
  • CLH Buy
  • Analyst Count
  • BMRN 22
  • CLH 8
  • Target Price
  • BMRN $93.43
  • CLH $249.25
  • AVG Volume (30 Days)
  • BMRN 2.2M
  • CLH 279.8K
  • Earning Date
  • BMRN 08-04-2025
  • CLH 07-30-2025
  • Dividend Yield
  • BMRN N/A
  • CLH N/A
  • EPS Growth
  • BMRN 152.82
  • CLH 4.50
  • EPS
  • BMRN 2.71
  • CLH 7.22
  • Revenue
  • BMRN $2,950,227,000.00
  • CLH $5,945,207,000.00
  • Revenue This Year
  • BMRN $12.23
  • CLH $5.21
  • Revenue Next Year
  • BMRN $9.99
  • CLH $5.07
  • P/E Ratio
  • BMRN $20.29
  • CLH $31.31
  • Revenue Growth
  • BMRN 19.36
  • CLH 8.52
  • 52 Week Low
  • BMRN $52.93
  • CLH $178.29
  • 52 Week High
  • BMRN $94.85
  • CLH $267.11
  • Technical
  • Relative Strength Index (RSI)
  • BMRN 35.12
  • CLH 53.78
  • Support Level
  • BMRN $54.46
  • CLH $220.96
  • Resistance Level
  • BMRN $58.17
  • CLH $230.39
  • Average True Range (ATR)
  • BMRN 1.39
  • CLH 3.40
  • MACD
  • BMRN -0.04
  • CLH -0.53
  • Stochastic Oscillator
  • BMRN 13.08
  • CLH 55.09

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.

About CLH Clean Harbors Inc.

Clean Harbors Inc is an environmental and industrial services provider. It provides parts cleaning and related environmental services to commercial, industrial, and automotive customers. Its business segments are Environmental Services and Safety-Kleen Sustainability Solutions. The company generates the majority of its revenues from the Environmental Services segment.

Share on Social Networks: